APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 44 filers reported holding APTINYX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $99 | -61.6% | 800 | -11.5% | 0.00% | – |
Q4 2022 | $258 | – | 904 | -13.9% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 1,050 | -86.0% | 0.00% | – |
Q1 2022 | $17,000 | +112.5% | 7,511 | +174.7% | 0.00% | – |
Q4 2021 | $8,000 | -57.9% | 2,734 | -66.3% | 0.00% | – |
Q3 2021 | $19,000 | -81.4% | 8,106 | -77.5% | 0.00% | – |
Q2 2021 | $102,000 | -53.0% | 35,969 | -50.3% | 0.00% | – |
Q1 2021 | $217,000 | +416.7% | 72,315 | +491.9% | 0.00% | – |
Q4 2020 | $42,000 | +425.0% | 12,218 | +457.9% | 0.00% | – |
Q3 2020 | $8,000 | -70.4% | 2,190 | -66.0% | 0.00% | – |
Q2 2020 | $27,000 | -60.9% | 6,435 | -79.8% | 0.00% | – |
Q1 2020 | $69,000 | +91.7% | 31,892 | +203.0% | 0.00% | – |
Q4 2019 | $36,000 | -10.0% | 10,524 | -9.4% | 0.00% | – |
Q3 2019 | $40,000 | -43.7% | 11,614 | -45.1% | 0.00% | – |
Q2 2019 | $71,000 | +121.9% | 21,145 | +169.3% | 0.00% | – |
Q1 2019 | $32,000 | -85.3% | 7,852 | -40.6% | 0.00% | – |
Q4 2018 | $218,000 | +202.8% | 13,213 | +430.0% | 0.00% | – |
Q3 2018 | $72,000 | – | 2,493 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
Orbimed Advisors | 538,500 | $300,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |